This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
In Beijing
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
This study exists to understand whether the medication OPC-64005 is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication OPC-64005 can improve attention, thinking, or day-to-day functioning.
Multiple locations, including Beverly Hills
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This study exists to better understand the safety of psilocybin treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to psilocybin treatment in practice and what may need to be adjusted.
In Baltimore
Depression, SuicidalityDrugFrom 18 Years to 65 Years
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.